Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.

JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...

Although the disease has left him shaken and he still experiences some weakness, Pawar is now back home with his family and is trying to get back to his normal life.

LOVELAND, CO, UNITED STATES, January 29, 2025 /EINPresswire / -- The newly opened Suite Health infusion clinic provides personalized infusion therapy options for clients seeking targeted infusion ...

Oral paclitaxel matched IV in progression-free survival but outperformed it in overall survival for second-line advanced gastric cancer.

The Food and Drug Administration said Tuesday that no IV glutathione product in the Philippines was approved for skin whitening.

Among those with advanced gastric cancer, oral Liporaxel showed superior overall survival outcomes versus IV Liporaxel as a ...

BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's Supplemental Biologics License Application ...

With the world running low on saline IV, a NSW vet discovers how to keep the precious resource flowing to animal clinics and ...

In the largest trial of its kind, patients receiving oral versus intravenous (IV) antibiotics for fracture-related infections ...

Dr. Eric K. Singhi shares his insights into the advantages of the subcutaneous formulation of Opdivo versus the IV version ...